Morozumi Tetsu, Preziosa Paolo, Meani Alessandro, Albergoni Matteo, Margoni Monica, Pagani Elisabetta, Filippi Massimo, Rocca Maria A
Neuroimaging Research Unit, Division of Neuroscience, IRCCS Ospedale San Raffaele, Milano, Italy.
Vita-Salute San Raffaele University, Milano, Italy.
J Neurol Neurosurg Psychiatry. 2023 Dec 14;95(1):29-36. doi: 10.1136/jnnp-2023-331482.
The hippocampus is a clinically relevant region where neurogenesis and neuroplasticity occur throughout the whole lifespan. Neuroinflammation and cardiorespiratory fitness (CRF) may influence hippocampal integrity by modulating the processes promoting neurogenesis and neuroprotection that contribute to the preservation of functions. This study aimed to investigate the effects of neuroinflammation and CRF on hippocampal volume in multiple sclerosis (MS) patients with relapsing-remitting (RR) and progressive (P) clinical phenotypes. The influence of neuroinflammation and CRF on brain, grey matter (GM) and thalamic volumes was also assessed to determine whether the effects were specific for the hippocampus.
Brain 3T structural MRI scans and maximum oxygen consumption (VOmax), a proxy of CRF, were acquired from 81 MS patients (27 RR and 54 P) and 45 age-matched and sex-matched healthy controls. T2-hyperintense white matter lesion volume (T2-LV) and choroid plexuses volume (CPV) were quantified as neuroinflammatory measures. Associations of demographic, clinical, neuroinflammatory and CRF measures with normalised brain, GM, hippocampal and thalamic volumes in relapsing-remitting MS (RRMS) and progressive MS patients were assessed using Shapley and best subset selection regression.
For most volumetric measures, the largest portions of variance were explained by T2-LV (variable importance (VI)=9.4-39.4) and CPV (VI=4.5-26.2). VOmax explained the largest portion of variance of normalised hippocampal volume only in RRMS patients (VI=16.9) and was retained as relevant predictor (standardised β=0.374, p=0.023) with T2-LV (standardised β=-0.330, p=0.016).
A higher CRF may play a specific neuroprotective role on MS patients' hippocampal integrity, but only in the RR phase of the disease.
海马体是一个具有临床相关性的区域,在整个生命周期中都会发生神经发生和神经可塑性。神经炎症和心肺适能(CRF)可能通过调节促进神经发生和神经保护的过程来影响海马体的完整性,而这些过程有助于维持功能。本研究旨在调查神经炎症和CRF对复发缓解型(RR)和进展型(P)临床表型的多发性硬化症(MS)患者海马体体积的影响。还评估了神经炎症和CRF对脑、灰质(GM)和丘脑体积的影响,以确定这些影响是否对海马体具有特异性。
对81名MS患者(27名RR型和54名P型)以及45名年龄和性别匹配的健康对照者进行了脑部3T结构MRI扫描,并测量了CRF的替代指标最大耗氧量(VOmax)。将T2高信号白质病变体积(T2-LV)和脉络丛体积(CPV)量化为神经炎症指标。使用Shapley和最佳子集选择回归评估复发缓解型MS(RRMS)和进展型MS患者的人口统计学、临床、神经炎症和CRF指标与标准化脑、GM、海马体和丘脑体积之间的关联。
对于大多数体积测量指标,方差的最大部分由T2-LV(可变重要性(VI)=9.4-39.4)和CPV(VI=4.5-26.2)解释。VOmax仅在RRMS患者中解释了标准化海马体体积方差的最大部分(VI=16.9),并与T2-LV(标准化β=-0.330,p=0.016)一起被保留为相关预测因子(标准化β=0.374,p=0.023)。
较高的CRF可能对MS患者的海马体完整性发挥特定的神经保护作用,但仅在疾病的RR期。